Fate Therapeutics, Inc. dividends
New to Digrin? See what a Digrin managed dividend portfolio looks like.
Sorry, we have no dividends for Fate Therapeutics, Inc. (FATE) at the moment. :(
FATE
Price: $3.87
52 week price:
Earnings Per Share: -1.64 USD
P/E Ratio: -3.92
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 1.6 million
Ebitda: -10.1 millionMarket Capitalization: 677.0 million